Share |

Health Care Law

Overview

Health care aims to prevent and treat illness and disease in order to maintain the physical and mental well-being of individuals. Nearly all industrialized nations provide universal, publicly-funded health care through a national system. The exception is the United States, where health care is largely provided by the private sector, although some public services are available for certain individuals.

State statutes comprise a large portion of law applicable to health care. State health care law ranges from regulation of the health insurance industry to rules governing cases of medical malpractice. State agencies and departments are usually responsible for implementing state health laws and regulations, as well as administering certain federally-funded health care programs.

Featured CasesSubscribe

  • GUNVALSON et al v. PTC THERAPEUTICS, INC.

    Plaintiffs Cheri and John Gunvalson, parents of Jacob Gunvalson, sought an order requiring Defendant PTC Therapeutics, Inc. to permit Jacob to participate as a protocol exception in the Phase IIa study extension for PTC124 for Duchenne Muscular Dystrophy. Alternatively, Plaintiffs sought an order that Defendant make available PTC124 to Jacob's pediatrician.
    New Jersey District Court
    Plaintiff
    Filed: July 16, 2008
    Plaintiff: JACOB GUNVALSON, CHERI AND JOHN GUNVALSON; Defendant: PTC THERAPEUTICS, INC.
    Last Docket Filed: April 7, 2009

LegislationSubscribe

RegulationsSubscribe

  • Rule - Listing of Color Additives Exempt From Certification: Astaxanthin Dimethyldisuccinate; ...

    Food and Drug Administration
    Rule
    Listing of Color Additives Exempt From Certification:
    Astaxanthin Dimethyldisuccinate; Confirmation of Effective Date
    ,
    5887 [2010-2522]
    DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 73 [Docket No. FDA-2007-C-0044] (formerly Docket No. 2007C-0474) Listing of Color Additives Exempt From Certification; Astaxanthin Dimethyldisuccinate; Confirmation of Effective Date AGENCY: Food and Drug Administration, HHS. ACTION: Final rule; confirmation of effective date. SUMMARY: The Food and Drug Administration (FDA) is confirming the effective date of December 8, 2009, for the final rule that appeared in... [read document]
    View Document | Download PDF
  • Rule - Listing of Color Additives Exempt From Certification: Paracoccus Pigment; Confirmation ...

    Food and Drug Administration
    Rule
    Listing of Color Additives Exempt From Certification:
    Paracoccus Pigment; Confirmation of Effective Date
    ,
    5887 [2010-2521]
    DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 73 [Docket No. FDA-2007-C-0456] (formerly Docket No. 2007C-0245) Listing of Color Additives Exempt From Certification; Paracoccus Pigment; Confirmation of Effective Date AGENCY: Food and Drug Administration, HHS. ACTION: Final rule; confirmation of effective date. SUMMARY: The Food and Drug Administration (FDA) is confirming the effective date of December 17, 2009, for the final rule that appeared in the Federal... [read document]
    View Document | Download PDF
  • Rule - Listing of Color Additives Exempt From Certification: Ractopamine; Monensin

    Food and Drug Administration
    Rule
    Listing of Color Additives Exempt From Certification:
    Ractopamine; Monensin
    ,
    5887-5888 [2010-2427]
    DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 558 [Docket No. FDA-2010-N-0002] New Animal Drugs for Use in Animal Feeds; Ractopamine; Monensin AGENCY: Food and Drug Administration, HHS. ACTION: Final rule. SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an original new animal drug application (NADA) filed by Elanco Animal Health, A Division of Eli Lilly and Co. The NADA provides for use of... [read document]
    View Document | Download PDF
  • Rule - Interim Final Rules under the Paul Wellstone and Pete Domenici Mental Health Parity and ...

    Centers for Medicare and Medicaid Services
    Rule
    Interim Final Rules under the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act (of 2008)
    ,
    5410-5451 [2010-2167]
    Tuesday, February 2, 2010 Part IV Department of the Treasury Internal Revenue Service 26 CFR Part 54 Department of Labor Employee Benefits Security Administration 29 CFR Part 2590 Department of Health and Human Services Centers for Medicare and Medicaid Services 45 CFR Part 146 Interim Final Rules Under the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008; Final Rule DEPARTMENT OF THE TREASURY Internal Revenue Service 26 CFR Part 54 [TD 9479] RIN... [read document]
    View Document | Download PDF
  • Rule - Implantation or Injectable Dosage Form New Animal Drugs: Miconazole, Polymixin B, and ...

    Food and Drug Administration
    Rule
    Implantation or Injectable Dosage Form New Animal Drugs:
    Miconazole, Polymixin B, and Prednisolone Suspension
    ,
    4692-4693 [2010-1794]
    DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 524 [Docket No. FDA-2010-N-0002] Ophthalmic and Topical Dosage Form New Animal Drugs; Miconazole, Polymixin B, and Prednisolone Suspension AGENCY: Food and Drug Administration, HHS. ACTION: Final rule. SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Janssen Pharmaceutica NV. The NADA provides for use of... [read document]
    View Document | Download PDF

ArticlesSubscribe